Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.448
https://www.valueinhealthjournal.com/article/S1098-3015(13)02353-X/fulltext
Title : Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02353-X&doi=10.1016/j.jval.2013.08.448
First page : A400
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 429
Categories :
Tags :
Regions :
ViH Article Tags :